(1.02%) 5 099.96 points
(0.40%) 38 240 points
(2.03%) 15 928 points
(0.11%) $83.66
(-1.16%) $1.619
(0.30%) $2 349.60
(-0.43%) $27.52
(0.42%) $924.40
(0.32%) $0.935
(0.67%) $11.02
(0.13%) $0.800
(-0.07%) $92.11
Live Chart Being Loaded With Signals
Biodesix, Inc. operates as a data-driven diagnostic solutions company in the United States. The company offers blood-based lung tests, including Nodify XL2 and Nodify CDT tests, together marketed as part of Nodify Lung Nodule Risk Assessment testing strategy, to assess the risk of lung cancer and help in identifying the appropriate treatment pathway and help physicians in reclassifying risk of malignancy in patients with suspicious lung nodules...
Stats | |
---|---|
Dagens volum | 13 758.00 |
Gjennomsnittsvolum | 137 349 |
Markedsverdi | 141.47M |
EPS | $0 ( 2024-03-01 ) |
Neste inntjeningsdato | ( $-0.150 ) 2024-05-08 |
Last Dividend | $0 ( N/A ) |
Next Dividend | $0 ( N/A ) |
P/E | -1.930 |
ATR14 | $0.00500 (0.41%) |
Date | Person | Action | Amount | type |
---|---|---|---|---|
2024-04-05 | Vazquez Chris | Buy | 22 | Series A Non-Voting Convertible Preferred Stock |
2024-04-05 | Strobeck Matthew | Buy | 7 392 | Series A Non-Voting Convertible Preferred Stock |
2024-04-05 | Strobeck Matthew | Buy | 1 304 | Series A Non-Voting Convertible Preferred Stock |
2024-04-05 | Schuler Jack W | Buy | 2 174 | Series A Non-Voting Convertible Preferred Stock |
2024-04-05 | Pestano Gary Anthony | Buy | 22 | Series A Non-Voting Convertible Preferred Stock |
INSIDER POWER |
---|
88.87 |
Last 100 transactions |
Buy: 13 131 293 | Sell: 601 205 |
Volum Korrelasjon
Biodesix, Inc. Korrelasjon
10 Mest positive korrelasjoner | |
---|---|
BNIXU | 0.898 |
HILS | 0.88 |
ENTA | 0.872 |
QNST | 0.861 |
FARO | 0.858 |
BNTX | 0.857 |
SBSI | 0.856 |
DYNT | 0.856 |
CZWI | 0.855 |
KPRX | 0.853 |
10 Mest negative korrelasjoner | |
---|---|
GPOR | -0.882 |
VRSK | -0.873 |
FTAA | -0.871 |
TBSAU | -0.868 |
NBSTU | -0.868 |
NVSA | -0.868 |
BLDR | -0.868 |
LGTO | -0.868 |
ITQ | -0.868 |
IRMD | -0.868 |
Visste du det?
Korrelasjon er en statistisk måling som beskriver forholdet mellom to variabler. Den varierer fra -1 til 1, hvor -1 indikerer en perfekt negativ korrelasjon (hvor en variabel øker, går den andre ned), 1 indikerer en perfekt positiv korrelasjon (hvor en variabel øker, går den andre også opp), og 0 indikerer ingen korrelasjon (det er ingen forhold mellom variablene).
Korrelasjon kan brukes til å analysere forholdet mellom to variabler, ikke bare aksjer. Det er vanligvis brukt innen områder som finans, økonomi, psykologi, og mer.
Biodesix, Inc. Korrelasjon - Valuta/Råvare
Biodesix, Inc. Økonomi
Annual | 2023 |
Omsetning: | $49.09M |
Bruttogevinst: | $33.21M (67.66 %) |
EPS: | $-0.640 |
FY | 2023 |
Omsetning: | $49.09M |
Bruttogevinst: | $33.21M (67.66 %) |
EPS: | $-0.640 |
FY | 2022 |
Omsetning: | $38.21M |
Bruttogevinst: | $24.06M (62.96 %) |
EPS: | $-1.910 |
FY | 2021 |
Omsetning: | $54.51M |
Bruttogevinst: | $54.51M (100.00 %) |
EPS: | $-1.580 |
Financial Reports:
No articles found.
Biodesix, Inc.
Biodesix, Inc. operates as a data-driven diagnostic solutions company in the United States. The company offers blood-based lung tests, including Nodify XL2 and Nodify CDT tests, together marketed as part of Nodify Lung Nodule Risk Assessment testing strategy, to assess the risk of lung cancer and help in identifying the appropriate treatment pathway and help physicians in reclassifying risk of malignancy in patients with suspicious lung nodules. It also offers GeneStrat ddPCR and VeriStrat tests, which are used in the diagnosis of lung cancer to measure the presence of mutations in the tumor and the state of the patient's immune system to establish the patient's prognosis and help guide treatment decisions; and GeneStrat NGS (NGS) test, a 72-hour blood-based NGS test. In addition, the company, through its partnership with Bio-Rad Laboratories, Inc., provides Bio-Rad SARS-CoV-2 ddPCR, a COVID-19 Test under Biodesix WorkSafe testing program; and Platelia SARS-CoV-2 Total Ab test, an antibody test for detecting a B-cell immune response to SARS-CoV-2 that indicate recent or prior infection. Further, it offers diagnostic and clinical research, as well as clinical trial testing services to biopharmaceutical companies; and discovers, develops, and commercializes companion diagnostics. The company was formerly known as Elston Technologies, Inc. Biodesix, Inc. was incorporated in 2005 and is headquartered in Boulder, Colorado.
Om Live Signaler
Live Trading signaler pa denne siden er ment til å hjelpe deg i beslutningsprossessen for når du bør KJØPE eller SELGE NA. Signalene har opp mot 1-minutt forsinkelse; som med alle andre indikatorer og signaler, er det en viss sjanse for feil eller feilkalkuleringer.
Live signalene er kun veiledende, og getagraph.com tar ikke noen form for ansvar basert pa handlinger gjort på disse signalene som beskrevet i Terms of Use. Signalene er basert på en rekke indikatorer og påliteligheten vil variere sterke fra aksje til aksje.